$CBRE
CBRE GROUP, INC. Stock $cbre

$cbre Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000113811821000023 Filed on April 29, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$5.939B	$5.889B
YoY Change	0.84%	14.68%
Cost Of Revenue	$4.720B	$4.713B
YoY Change	0.15%	17.17%
Gross Profit	$1.219B	$1.176B
YoY Change	3.64%	5.66%
Gross Profit Margin	20.53%	19.98%
Selling, General & Admin	$828.3M	$790.1M
YoY Change	4.83%	-0.74%
% of Gross Profit	67.93%	67.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$122.1M	$113.8M
YoY Change	7.29%	7.56%
% of Gross Profit	10.01%	9.67%
Operating Expenses	$950.5M	$903.9M
YoY Change	5.16%	-0.42%
Operating Profit	$269.1M	$220.3M
YoY Change	22.15%	51.94%
Interest Expense	$73.50M	$4.600M
YoY Change	1497.83%	-79.76%
% of Operating Profit	27.31%	2.09%
Other Income/Expense, Net	$2.732M	-$193.0K
YoY Change	-1515.54%	-100.93%
Pretax Income	$345.3M	$224.7M
YoY Change	53.67%	4.66%
Income Tax	$76.33M	$51.18M
% Of Pretax Income	22.1%	22.78%
Net Earnings	$266.2M	$172.2M
YoY Change	54.59%	4.74%
Net Earnings / Revenue	4.48%	2.92%
Basic Earnings Per Share	$0.79	$0.51
Diluted Earnings Per Share	$0.78	$0.51
COMMON SHARES
Basic Shares Outstanding	335.9M shares	335.0M shares
Diluted Shares Outstanding	339.6M shares	339.7M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.910B	$628.0M
YoY Change	204.14%	3.8%
Cash & Equivalents	$1.910B	$732.7M
Short-Term Investments
Other Short-Term Assets	$318.7M	$682.0M
YoY Change	-53.27%	-0.87%
Inventory
Prepaid Expenses	$281.7M
Receivables	$4.233B	$4.592B
Other Receivables	$758.0M	$1.362B
Total Short-Term Assets	$7.906B	$7.264B
YoY Change	8.84%	3.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$774.3M	$1.897B
YoY Change	-59.18%	9.72%
Goodwill	$3.805B	$3.674B
YoY Change	3.56%
Intangibles	$1.370B
YoY Change
Long-Term Investments	$682.6M	$423.0M
YoY Change	61.36%	85.53%
Other Assets	$748.6M	$691.4M
YoY Change	8.28%	-6.06%
Total Long-Term Assets	$9.342B	$8.416B
YoY Change	11.0%	9.36%
TOTAL ASSETS
Total Short-Term Assets	$7.906B	$7.264B
Total Long-Term Assets	$9.342B	$8.416B
Total Assets	$17.25B	$15.68B
YoY Change	10.0%	6.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.469B	$2.365B
YoY Change	4.4%	28.95%
Accrued Expenses	$2.218B	$2.115B
YoY Change	4.87%	6.07%
Deferred Revenue	$174.4M	$107.0M
YoY Change	62.99%	-7.07%
Short-Term Debt	$681.0M	$1.264B
YoY Change	-46.12%	-33.38%
Long-Term Debt Due	$1.402M	$1.718M
YoY Change	-18.39%	-33.23%
Total Short-Term Liabilities	$5.773B	$6.065B
YoY Change	-4.82%	0.91%
LONG-TERM LIABILITIES
Long-Term Debt	$1.848B	$1.755B
YoY Change	5.35%	-0.32%
Other Long-Term Liabilities	$608.8M	$461.7M
YoY Change	31.87%	3.11%
Total Long-Term Liabilities	$2.457B	$2.216B
YoY Change	10.87%	0.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.773B	$6.065B
Total Long-Term Liabilities	$2.457B	$2.216B
Total Liabilities	$9.593B	$9.511B
YoY Change	0.86%	0.23%
SHAREHOLDERS EQUITY
Retained Earnings	$6.796B	$5.950B
YoY Change	14.22%	27.27%
Common Stock	$1.017B	$1.030B
YoY Change	-1.31%	-8.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.230B	$6.129B
YoY Change
Total Liabilities & Shareholders Equity	$17.25B	$15.68B
YoY Change	10.0%	6.72%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$266.2M	$172.2M
YoY Change	54.59%	4.74%
Depreciation, Depletion And Amortization	$122.1M	$113.8M
YoY Change	7.29%	7.56%
Cash From Operating Activities	-$193.4M	-$128.8M
YoY Change	50.22%	-67.2%
INVESTING ACTIVITIES
Capital Expenditures	$29.60M	$62.24M
YoY Change	-52.45%	9.23%
Acquisitions
YoY Change
Other Investing Activities	-$16.00K	-$9.068M
YoY Change	-99.82%	227.25%
Cash From Investing Activities	-$193.9M	-$92.23M
YoY Change	110.24%	24.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$61.11M	$50.03M
YoY Change	22.15%	10.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$402.0M	-$101.4M
YoY Change	-496.37%	-133.8%
NET CHANGE
Cash From Operating Activities	-$193.4M	-$128.8M
Cash From Investing Activities	-$193.9M	-$92.23M
Cash From Financing Activities	$402.0M	-$101.4M
Net Change In Cash	-$37.54M	-$361.1M
YoY Change	-89.6%	104.82%
FREE CASH FLOW
Cash From Operating Activities	-$193.4M	-$128.8M
Capital Expenditures	$29.60M	$62.24M
Free Cash Flow	-$223.0M	-$191.0M
YoY Change	16.77%	-57.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001138118
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssets
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssets
CY2021Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-32205
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	CBRE GROUP, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3391143
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2100 McKinney Avenue
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1250
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75201
CY2021Q1	dei	City Area Code CityAreaCode	214
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	979-6100
CY2021Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.01 par value per share
CY2021Q1	dei	Trading Symbol TradingSymbol	“CBRE”
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	335657390	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1910326000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1896188000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	91381000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	143059000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	88972000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	95533000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4232561000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4394954000	USD
CY2021Q1	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	686317000	USD
CY2020Q4	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	1411170000	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	281658000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	294992000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	313648000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	318191000	USD
CY2021Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	71681000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	93756000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	318719000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	293321000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	7906291000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	8845631000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	774301000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1367913000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	815009000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	3804678000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	3821609000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1603208000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1556537000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1370484000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1000729000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1020352000	USD
CY2021Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	309749000	USD
CY2020Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	116314000	USD
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	682559000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	452365000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	135587000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	153636000	USD
CY2021Q1	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	295494000	USD
CY2020Q4	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	277630000	USD
CY2021Q1	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	37130000	USD
CY2020Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	43555000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	90320000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	91529000	USD
CY2021Q1	us-gaap	Assets Held In Trust AssetsHeldInTrust	402507000	USD
CY2020Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	402501000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	748648000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	747413000	USD
CY2021Q1	us-gaap	Assets Assets	17248728000	USD
CY2020Q4	us-gaap	Assets Assets	18039143000	USD
CY2021Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2469434000	USD
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2692939000	USD
CY2021Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1353219000	USD
CY2020Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1287383000	USD
CY2021Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	657552000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1183786000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	206772000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	208526000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	174413000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	162045000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	64105000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	57892000	USD
CY2021Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	675473000	USD
CY2020Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	1383964000	USD
CY2021Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	5425000	USD
CY2020Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	5330000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1402000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1514000	USD
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	165008000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	160604000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5772803000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7143983000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1848346000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1380202000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1090740000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1116795000	USD
CY2021Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	93885000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	87954000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	54761000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	54761000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	123562000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	124485000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	608848000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	625303000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	9592945000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	10533483000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	335918173	shares
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	384399000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	385573000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	335918173	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	335561345	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	335561345	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	3359000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	3356000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1013287000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1074639000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6796259000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6530057000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-582535000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-529726000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	7230370000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	7078326000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	41014000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	41761000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7271384000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7120087000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17248728000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18039143000	USD
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD
CY2020Q1	us-gaap	Revenues Revenues	5889168000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	4719546000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	4712674000	USD
CY2021Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	828327000	USD
CY2020Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	790066000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122078000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	113794000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75171000	USD
CY2021Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	5669951000	USD
CY2020Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	5691705000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	156000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	22827000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	269084000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	220290000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	83594000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	20631000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2732000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-193000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-10106000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-16016000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	345304000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	224712000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76327000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51182000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	173530000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2775000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1335000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	172195000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335860494	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	334969826	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339580504	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339737911	shares
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	173530000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-52346000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-172374000	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-107000	USD
CY2020Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-114000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-678000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	909000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-52917000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-171351000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	216060000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2179000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2667000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1275000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	213393000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	904000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	173530000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122078000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	113794000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1609000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1501000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	72045000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	52373000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75171000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	2732000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-193000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	731000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	83594000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	20631000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9059000	USD
CY2021Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	32986000	USD
CY2021Q1	cbre	Share Based Compensation Expense Reversal ShareBasedCompensationExpenseReversal	-35786000	USD
CY2020Q1	cbre	Share Based Compensation Expense Reversal ShareBasedCompensationExpenseReversal	1239000	USD
CY2020Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	29185000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4643685000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	3595631000	USD
CY2021Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3909261000	USD
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3859407000	USD
CY2021Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	-708491000	USD
CY2020Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	281657000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-1578000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-13292000	USD
CY2021Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	2398000	USD
CY2020Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	3559000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29597000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62241000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	3017000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	4925000	USD
CY2021Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	15901000	USD
CY2020Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	-7742000	USD
CY2021Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	-161221000	USD
CY2020Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	-52796000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-245522000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-27089000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-469213000	USD
CY2020Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-605950000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-41660000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-108609000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-2381000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	25610000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-193448000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-128773000	USD
CY2021Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	6795000	USD
CY2021Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	2726000	USD
CY2020Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	25897000	USD
CY2021Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	168392000	USD
CY2020Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	32155000	USD
CY2020Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	18994000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-16000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-9068000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-193904000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-92231000	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2020Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	331671000	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2020Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	331701000	USD
CY2021Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	23737000	USD
CY2020Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	492255000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	61108000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50028000	USD
CY2021Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	512000	USD
CY2020Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	6230000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	34883000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	36873000	USD
CY2021Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	72000	USD
CY2020Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	622000	USD
CY2021Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2652000	USD
CY2020Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	497000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-14943000	USD
CY2020Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-8377000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	401966000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-101413000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-52154000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-38633000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37540000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-361050000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2039247000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1093745000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2001707000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	732695000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	15080000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	27290000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	38508000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-55897000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7120087000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	268977000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35786000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	34883000	USD
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	64142000	USD
CY2021Q1	cbre	Noncontrolling Interest Increase From Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterestHolders	72000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2652000	USD
CY2021Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1056000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7271384000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6273112000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-52346000	USD
CY2021Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-107000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-678000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	173530000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1239000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	36873000	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	50028000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-172374000	USD
CY2020Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-114000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	909000	USD
CY2020Q1	cbre	Noncontrolling Interest Increase From Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterestHolders	622000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	497000	USD
CY2020Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	17729000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6169547000	USD
CY2021Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Readers of this Quarterly Report on Form 10-Q (Quarterly Report) should refer to the audited financial statements and notes to consolidated financial statements of CBRE Group, Inc., a Delaware corporation (which may be referred to in these financial statements as “the company,” “we,” “us” and “our”), for the year ended December 31, 2020, which are included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1138118/000113811821000012/cbre-20201231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Annual Report on Form 10-K (2020 Annual Report)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the United States Securities and Exchange Commission (SEC) and also available on our website (www.cbre.com), since we have omitted from this Quarterly Report certain footnote disclosures which would substantially duplicate those contained in such audited financial statements. You should also refer to Note 2, Significant Accounting Policies, in the notes to consolidated financial statements in our 2020 Annual Report for further discussion of our significant accounting policies and estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Considerations Related to the Covid-19 Pandemic</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Covid-19 pandemic has primarily impacted the Advisory Services segment, chiefly property sales and leasing. Many property owners and occupiers have put transactions on hold and withdrawn existing mandates, sharply reducing sales and leasing volumes. Although progress has been made with the distribution of vaccines and economic conditions in some parts of the world, chiefly the U.S. and China, have been improving, we expect operating challenges to continue, as Covid-19 caseloads remain high, business travel and face-to-face business dealings are limited and the majority of workers remain out of their offices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 (Fair Value Measurements) and Note 10 (Commitments and Contingencies) for further discussion of Covid-19 considerations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statement Preparation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with the rules applicable to quarterly reports on Form 10-Q and include all information and footnotes required for interim financial statement presentation, but do not include all disclosures required under accounting principles generally accepted in the United States (U.S.), or GAAP, for annual financial statements. In our opinion, all adjustments (consisting of normal recurring adjustments, except as otherwise noted) considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions about future events, including the impact </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Covid-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> may have on our business. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported and reported amounts of revenue and expenses. Such estimates include the value of goodwill, intangibles and other long-lived assets, real estate assets, accounts receivable, contract assets, operating lease assets, investments in unconsolidated subsidiaries and assumptions used in the calculation of income taxes, retirement and other post-employment benefits, among others. These estimates and assumptions are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the 2020 financial statements to conform with the 2021 presentation.</span></div>
CY2020Q4	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	1411170000	USD
CY2021Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3909261000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	25696000	USD
CY2021Q1	cbre	Sale Of Mortgage Loans Held For Sale SaleOfMortgageLoansHeldForSale	4617989000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Mortgage Loans Held For Sale ProceedsFromCollectionOfMortgageLoansHeldForSale	25696000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4643685000	USD
CY2021Q1	cbre	Net Increase Decrease In Mortgage Servicing Rights Included In Warehouse Receivables NetIncreaseDecreaseInMortgageServicingRightsIncludedInWarehouseReceivables	-16125000	USD
CY2021Q1	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	686317000	USD
CY2021Q1	cbre	Fair Value Assets And Liabilities Measured On Recurring Basis Number Of Investments Measured Using Unobservable Inputs FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisNumberOfInvestmentsMeasuredUsingUnobservableInputs	1	investment
CY2021Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	92800000	USD
CY2020Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	66300000	USD
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1860358000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1387743000	USD
CY2021Q1	cbre	Debt Instrument Redemption Price Discount Rate Adjustment To Treasury Rate DebtInstrumentRedemptionPriceDiscountRateAdjustmentToTreasuryRate	0.0020
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1402000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1514000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	10610000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6027000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1848346000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1380202000	USD
CY2021Q1	cbre	Debt Instrument Principal Amount Issued Percentage Of Face Value DebtInstrumentPrincipalAmountIssuedPercentageOfFaceValue	0.98451
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1000729000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1020352000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	114503000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	117805000	USD
CY2021Q1	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1115232000	USD
CY2020Q4	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1138157000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	206772000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	208526000	USD
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	35896000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	39298000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1090740000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1116795000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	78473000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	78881000	USD
CY2021Q1	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1411881000	USD
CY2020Q4	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1443500000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	24214000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	61310000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	10448000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	14683000	USD
CY2021Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	5940000	USD
CY2020Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	6888000	USD
CY2021Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	-1563000	USD
CY2020Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	-517000	USD
CY2021Q1	cbre	Funded Loan Principal Amount Outstanding FundedLoanPrincipalAmountOutstanding	34100000000	USD
CY2021Q1	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	58800000	USD
CY2020Q4	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	57100000	USD
CY2021Q1	cbre	Assets Available For Recourse AssetsAvailableForRecourse	677500000	USD
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	144000000.0	USD
CY2021Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	144000000.0	USD
CY2021Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	42100000	USD
CY2021Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	42100000	USD
CY2021Q1	cbre	Commitments To Investment In Future Real Estate Investment CommitmentsToInvestmentInFutureRealEstateInvestment	91100000	USD
CY2021Q1	cbre	Commitments To Investment In Unconsolidated Entity CommitmentsToInvestmentInUnconsolidatedEntity	31300000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76300000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51200000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	25100000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.221
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	166800000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1700000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1700000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3100000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	4800000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	172195000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335860494	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	334969826	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	172195000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335860494	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	334969826	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3720010	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	4768085	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339580504	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339737911	shares
CY2020Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	144039000	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2021Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	285900000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5778432000	USD
CY2021Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	160447000	USD
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5745129000	USD
CY2020Q1	us-gaap	Revenues Revenues	5889168000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	449200000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	313600000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	471800000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	318200000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	177400000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	174400000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	164100000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	162000000.0	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	136600000	USD
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD
CY2020Q1	us-gaap	Revenues Revenues	5889168000	USD
CY2021Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	545054000	USD
CY2020Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	482953000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	266202000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	172195000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122078000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	113794000	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	75171000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-10106000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-16016000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76327000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51182000	USD
CY2021Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	15332000	USD
CY2020Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	-7784000	USD
CY2021Q1	cbre	Impact Of Fair Value Adjustments To Assets Acquired In Business ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness	1099000	USD
CY2020Q1	cbre	Impact Of Fair Value Adjustments To Assets Acquired In Business ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness	5753000	USD
CY2021Q1	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2020Q1	us-gaap	Restructuring Costs RestructuringCosts	3241000	USD
CY2021Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	USD
CY2020Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	783000	USD
CY2021Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	545054000	USD
CY2020Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	482953000	USD
CY2021Q1	us-gaap	Revenues Revenues	5938879000	USD
CY2020Q1	us-gaap	Revenues Revenues	5889168000	USD

Files In Submission

Name	View Source	Status
0001138118-21-000023-index-headers.html	Edgar Link	pending
0001138118-21-000023-index.html	Edgar Link	pending
0001138118-21-000023.txt	Edgar Link	pending
0001138118-21-000023-xbrl.zip	Edgar Link	pending
cbre-20210331.htm	Edgar Link	pending
cbre-20210331.xsd	Edgar Link	pending
cbre-20210331x10qxex221.htm	Edgar Link	pending
cbre-20210331x10qxex311.htm	Edgar Link	pending
cbre-20210331x10qxex312.htm	Edgar Link	pending
cbre-20210331x10qxex32.htm	Edgar Link	pending
cbre-20210331_cal.xml	Edgar Link	unprocessable
cbre-20210331_def.xml	Edgar Link	unprocessable
cbre-20210331_g1.jpg	Edgar Link	pending
cbre-20210331_htm.xml	Edgar Link	completed
cbre-20210331_lab.xml	Edgar Link	unprocessable
cbre-20210331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBRE
CBRE GROUP, INC. Stock $cbre

2021 Q1 Form 10-Q Financial Statement

#000113811821000023 Filed on April 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE CBRE GROUP, INC. Stock $cbre

2021 Q1 Form 10-Q Financial Statement

#000113811821000023 Filed on April 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE
CBRE GROUP, INC. Stock $cbre